Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Advanced Therapies
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
1 / 28
1 / 28
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-CL-21
Feb 28, 2025
Radioconjugates
Rising Interest in Radioconjugate Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-02-25-CL-20
Feb 25, 2025
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16
Feb 19, 2025
Gene Therapy
Genprex Provides Update on Diabetes Gene Therapy Program
Genprex
PR-02-25-NI-15
Feb 19, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-02-25-CL-11
Feb 13, 2025
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Feb 11, 2025
Clinical Trials
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
Carsgen Therapeutics
PR-02-25-NI-09
Feb 11, 2025
RNA
Enabling Cost-Effective, Rapid Access to RNA Vaccines and Therapeutics with Enzymatically Generated z- dbDNA
Lisa Caproni
Touchlight
PAO-01-25-CL-08
Feb 10, 2025
Cell Therapy
From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials
Dominic Mancini
OrganaBio
PAO-01-25-CL-13
Jan 28, 2025
Advanced Therapies
Ensuring Nuclease Free Process Consumables for Biopharma Applications
Richard Fry
Sanisure
PAO-01-25-CL-05
Jan 22, 2025
Protein Portfolio
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
Bio-Techne Corporation
PR-01-25-NI-05
Jan 10, 2025
Sustainability
Synthetic DNA Delivers a Sustainable Future for Genetic Medicines
Touchlight
PAO-01-25-CL-04
Jan 07, 2025
RNA
Screening T7 Polymerases to Optimize xRNA Yield and Quality
Jing Zhu, Ph.D.
ReciBioPharm
PAO-01-25-CL-02
Jan 07, 2025
Announcement
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene
Nona Biosciences
PR-01-25-NI-02
Jan 03, 2025
Nonviral Delivery
Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA
Lisa Caproni
Touchlight
PAO-12-24-CL-4
Dec 16, 2024
Clinical Trials
Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial in Patients
Beacon Therapeutics
PR-12-24-NI-131
Dec 06, 2024
AAV Quality
Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.
Rentschler Biopharma SE
PAO-11-24-CL-06
Dec 02, 2024
CASGEVY
Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy
Orsini Healthcare
PR-11-24-NI-103
Nov 15, 2024
Gene Therapy
FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
U.S. Food & Drug Administration
PR-11-24-NI-100
Nov 15, 2024
RNA
Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples
Lexogen
PR-11-24-NI-99
Nov 15, 2024
